Medical Blog About Treatment Abroad

Neuroendocrine tumors have shown a significant increase in prevalence over the past two decades. Between 2000 and 2018, the age-standardized incidence increased from 4.9 to 8.2 cases per 100,000 population, with the most pronounced increase being among grade 1 tumors, early stages, and appendix neoplasms. Despite improved diagnostic...

The reality drives the urgent need for novel and more effective astrocytoma treatments. Astrocytoma group of neoplasms includes relatively slow-growing grades I–III and grade IV – glioblastoma, mentioned among the most lethal cancers. In the U.S., gliomas strike roughly 6 per 100,000 people annually. That is, each year, about 25,400...

Prostate cancer (PC) is one of the most common cancers men face – second worldwide, in fact. In 2022 alone, around 1.47 million new cases were diagnosed, making up 14.2% of all cancer diagnoses in men. Those numbers are significant. But so is this: more men are living well after a prostate cancer diagnosis than ever before. Here's something...

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a highly targeted cancer treatment used for tumors that have spread within the abdominal cavity. Unlike standard chemotherapy, HIPEC delivers heated, high-dose drugs directly into the abdomen after surgical tumor removal – this process allows for stronger local action with fewer...

Bladder cancer is a major global health concern. Bladder tumors are among the top ten most common malignancies worldwide. It affects both sexes but occurs more frequently in men (especially those over the age of 55). According to the U.S. National Cancer Institute, approximately 84,870 new cases of bladder cancer were diagnosed in 2024...

When facing a pancreatic cancer diagnosis, hope can seem distant, but Germany's medical innovation offers a beacon of possibility where standard treatments may have reached their limits. Pancreatic cancer treatment centers in Germany have transformed patient care from a realm of limited options to one of groundbreaking possibilities...

Cervical cancer remains one of the most common gynecological malignancies worldwide, with significant disparities in incidence and survival depending on geography and access to care. According to the World Health Organization, over 600,000 women are diagnosed with cervical cancer each year globally, and nearly 340,000...

Cervical cancer is one of the most frightening diagnoses to give to a woman. More than half a million new cases are reported every year worldwide, and half are diagnosed at late stages when the patient already shows signs of the disease. New technologies in screening and vaccines have enhanced early diagnosis, but problems remain...